Suchergebnisse - "Carraro, Maria Cristina"

PubPharm (12)

1

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

enthalten in: Blood advances | 2022

von Maffioli, M. | Mora, B. | Ball, S. | +24

2

Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia : Final report of the PhilosoPhi34 study

enthalten in: European journal of haematology | 2021

von Pungolino, E. | D'adda, M. | De Canal, G. | +18

3

Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in AsthmaSecondary to Chronic Myeloid Leukemia with Hypereosinophilia

enthalten in: Anti-inflammatory & anti-allergy agents in medicinal chemistry | 2021

von Gidaro, A. | Salvi, E. | Carraro, M. | +2

4

Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia

enthalten in: Anti-inflammatory & anti-allergy agents in medicinal chemistry | 2021

von Gidaro, A. | Salvi, E. | Carraro, M. | +2

5

Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia : Final report of the PhilosoPhi34 study

enthalten in: European Journal of Haematology | 2021

von Pungolino, E. | D'adda, M. | De Canal, G. | +18

6

Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML) : the GIMS (Glivec to Imatinib Switch) study

enthalten in: Blood research | 2020

von Gemelli, M. | Elli, E. | Elena, C. | +16

7

Second primary malignancies in ruxolitinib-treated myelofibrosis : real-world evidence from 219 consecutive patients

enthalten in: Blood advances | 2019

von Maffioli, M. | Giorgino, T. | Mora, B. | +25

8

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment

enthalten in: PloS one | 2019

von Trojani, A. | Pungolino, E. | Dal Molin, A. | +21

9

Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia

enthalten in: American journal of hematology | 2018

von Pungolino, E. | Rossi, G. | De Canal, G. | +19

10

Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment

enthalten in: Cancer biomarkers : section A of Disease markers | 2017

von Trojani, A. | Pungolino, E. | Rossi, G. | +18